Newer approaches to the diagnosis of early onset neonatal sepsis
- PMID: 16632649
 - PMCID: PMC2672708
 - DOI: 10.1136/adc.2004.064188
 
Newer approaches to the diagnosis of early onset neonatal sepsis
Abstract
Accurate and timely diagnosis of early onset neonatal sepsis remains challenging to the clinician and the laboratory. A test with a rapid turnaround time with 100% sensitivity, rather than high specificity, which allows accurate diagnosis and appropriate antimicrobial treatment or which allows antibiotics to be safely withheld in non-infected infants, is desirable. Many potential markers (acute phase reactants, cell surface markers, cytokines) are not routinely available to the laboratory, and most likely combinations of markers will ensure greater diagnostic accuracy. In the future, molecular biology techniques offer the prospect of rapid identification of both pathogens and antimicrobial resistance markers.
Conflict of interest statement
Competing interests: none declared
References
- 
    
- Chiesa C, Pellegrini G, Panero A. C‐reactive protein, interleukin‐6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 20034960–68. - PubMed
 
 - 
    
- Mehr S, Doyle L W. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 200019879–887. - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical